KYTX
Kyverna Therapeutics, Inc.
6.80$
-2.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 90.2% | 79.6% | 80.7% | 95.4% | 96.3% | |
| 89.0% | 56.4% | 46.1% | 31.7% | 42.2% | |
| 89.0% | 76.7% | 76.5% | 93.9% | 95.0% | |
| 154.1% | 210.6% | 34.6% | 12.5% | 20.9% | |
| 18.6% | 17.9% | 26.4% | 11.1% | 12.4% | |
| 1.0% | 3.4% | 3.9% | 1.3% | 1.4% | |
| 0.9% | 2.2% | 5.8% | 1.5% | 1.8% | |
| – | – | – | – | 8.4% | |
| -54.1% | -110.6% | 65.4% | 87.5% | 79.1% | |
| -54.7% | -113.1% | -180.9% | -86.5% | -144.6% | |
| 30.2% | 38.6% | 895.8% | 12.6% | 15.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.